Study highlights the potential of psilocybin in treating obsessive-compulsive disorder

A new study highlights the potential of psilocybin, a psychedelic compound, in treating obsessive-compulsive disorder (OCD) and Tourette’s Syndrome.

Four years non-diabetic status after impaired glucose tolerance diagnosis cuts cardiovascular risks

Maintaining non-diabetic status for at least four years after impaired glucose tolerance diagnosis significantly lowers the risk of cardiovascular complications and mortality.

July 11, 2024

Federal bill would keep addiction medication from triggering a child abuse investigation

When Keri McCallum‘s doctor prescribed her Suboxone, she was told it was the “safest thing for me.” It would aid her in her recovery from

October 4, 2023

Drinking water quality violations disproportionately affect the most vulnerable communities, study reveals

A new study published in IOP Publishing’s journal Environmental Research Letters examines the links between drinking water quality violations and social vulnerability in the United

September 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.